<?xml version="1.0" encoding="utf-8"?>
<rr:ResultsReport>
	<rr:ResultsPayload>
		<FinalReport>
			<Sample>
				<FM_Id>AA -23-03858</FM_Id>
				<SampleId></SampleId>
				<BlockId>M112-10168_(PT23067)</BlockId>
				<TRFNumber></TRFNumber>
				<TestType></TestType>
				<SpecFormat>Lymph node  Type</SpecFormat>
				<ReceivedDate>Jun 13, 2023</ReceivedDate>
			</Sample>
			<PMI>
				<ReportId></ReportId>
				<MRN>49533166</MRN>
				<FullName>許麗華</FullName>
				<FirstName></FirstName>
				<LastName></LastName>
				<SubmittedDiagnosis>Lung adenocarcinoma</SubmittedDiagnosis>
				<Gender>Female</Gender>
				<DOB>Sep 16, 1945</DOB>
				<OrderingMD>趙恒勝醫師</OrderingMD>
				<OrderingMDId></OrderingMDId>
				<Pathologist></Pathologist>
				<CopiedPhysician1></CopiedPhysician1>
				<MedFacilName>臺北榮總</MedFacilName>
				<MedFacilID></MedFacilID>
				<SpecSite></SpecSite>
				<CollDate></CollDate>
				<ReceivedDate></ReceivedDate>
				<CountryOfOrigin></CountryOfOrigin>
			</PMI>
		</FinalReport>
		<variant-report>
			<short_variants>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>-</depth>
					<gene>ATR</gene>
					<percent_reads>NM_001184</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.5381</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.339G&gt;A</cds_effect>
					<depth>1031</depth>
					<gene>FANCC</gene>
					<percent_reads>66.3%</percent_reads>
					<protein_effect>W113*</protein_effect>
					<transcript>NM_000136</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.844C&gt;T</cds_effect>
					<depth>92</depth>
					<gene>TP53</gene>
					<percent_reads>38.8%</percent_reads>
					<protein_effect>R282W</protein_effect>
					<transcript>NM_000546</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.2588C&gt;A</cds_effect>
					<depth>2047</depth>
					<gene>AMER1</gene>
					<percent_reads>20.2%</percent_reads>
					<protein_effect>P863H</protein_effect>
					<transcript>NM_152424</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.363_383del</cds_effect>
					<depth>1748</depth>
					<gene>ARID1B</gene>
					<percent_reads>51.0%</percent_reads>
					<protein_effect>Q125_Q131del</protein_effect>
					<transcript>NM_017519</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.6460T&gt;C</cds_effect>
					<depth>320</depth>
					<gene>BRCA2</gene>
					<percent_reads>52.8%</percent_reads>
					<protein_effect>Y2154H</protein_effect>
					<transcript>NM_000059</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.4416G&gt;T</cds_effect>
					<depth>2258</depth>
					<gene>CREBBP</gene>
					<percent_reads>27.2%</percent_reads>
					<protein_effect>W1472C</protein_effect>
					<transcript>NM_004380</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.499C&gt;G</cds_effect>
					<depth>362</depth>
					<gene>CYP2B6</gene>
					<percent_reads>83.4%</percent_reads>
					<protein_effect>P167A</protein_effect>
					<transcript>NM_000767</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>38.6%</depth>
					<gene>EP300</gene>
					<percent_reads>-</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.2379+8T&gt;C</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.2152G&gt;A</cds_effect>
					<depth>2140</depth>
					<gene>EPHB1</gene>
					<percent_reads>49.8%</percent_reads>
					<protein_effect>V718M</protein_effect>
					<transcript>NM_004441</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>-</depth>
					<gene>ERBB4</gene>
					<percent_reads>NM_005235</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.884</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3550C&gt;T</cds_effect>
					<depth>1654</depth>
					<gene>FANCA</gene>
					<percent_reads>45.0%</percent_reads>
					<protein_effect>R1184W</protein_effect>
					<transcript>NM_000135</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.2094G&gt;C</cds_effect>
					<depth>1547</depth>
					<gene>FANCA</gene>
					<percent_reads>18.9%</percent_reads>
					<protein_effect>E698D</protein_effect>
					<transcript>NM_000135</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1428C&gt;G</cds_effect>
					<depth>631</depth>
					<gene>FLCN</gene>
					<percent_reads>29.0%</percent_reads>
					<protein_effect>D476E</protein_effect>
					<transcript>NM_144997</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.628A&gt;G</cds_effect>
					<depth>1237</depth>
					<gene>FLT1</gene>
					<percent_reads>33.8%</percent_reads>
					<protein_effect>T210A</protein_effect>
					<transcript>NM_002019</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1366C&gt;T</cds_effect>
					<depth>1407</depth>
					<gene>IKBKE</gene>
					<percent_reads>77.0%</percent_reads>
					<protein_effect>R456W</protein_effect>
					<transcript>NM_014002</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>54.4%</depth>
					<gene>KAT6A</gene>
					<percent_reads>-</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.600+5G&gt;T</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.5333G&gt;C</cds_effect>
					<depth>1609</depth>
					<gene>MED12</gene>
					<percent_reads>44.9%</percent_reads>
					<protein_effect>S1778T</protein_effect>
					<transcript>NM_005120</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.147A&gt;C</cds_effect>
					<depth>2054</depth>
					<gene>MRE11</gene>
					<percent_reads>18.0%</percent_reads>
					<protein_effect>E49D</protein_effect>
					<transcript>NM_005591</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.22016G&gt;A</cds_effect>
					<depth>1164</depth>
					<gene>MUC16</gene>
					<percent_reads>29.3%</percent_reads>
					<protein_effect>S7339N</protein_effect>
					<transcript>NM_024690</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>-</depth>
					<gene>NOTCH1</gene>
					<percent_reads>NM_017617</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.3902</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.2597G&gt;C</cds_effect>
					<depth>2473</depth>
					<gene>PIK3C3</gene>
					<percent_reads>32.5%</percent_reads>
					<protein_effect>S866T</protein_effect>
					<transcript>NM_002647</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1316G&gt;T</cds_effect>
					<depth>2759</depth>
					<gene>PRKCG</gene>
					<percent_reads>58.3%</percent_reads>
					<protein_effect>G439V</protein_effect>
					<transcript>NM_002739</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3113G&gt;T</cds_effect>
					<depth>3484</depth>
					<gene>PTPRD</gene>
					<percent_reads>25.7%</percent_reads>
					<protein_effect>W1038L</protein_effect>
					<transcript>NM_002839</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1643C&gt;T</cds_effect>
					<depth>658</depth>
					<gene>RPTOR</gene>
					<percent_reads>47.6%</percent_reads>
					<protein_effect>T548M</protein_effect>
					<transcript>NM_020761</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1093G&gt;A</cds_effect>
					<depth>2298</depth>
					<gene>RPTOR</gene>
					<percent_reads>9.0%</percent_reads>
					<protein_effect>V365I</protein_effect>
					<transcript>NM_020761</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1619C&gt;A</cds_effect>
					<depth>2050</depth>
					<gene>STAT3</gene>
					<percent_reads>15.1%</percent_reads>
					<protein_effect>S540*</protein_effect>
					<transcript>NM_139276</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3023G&gt;C</cds_effect>
					<depth>3565</depth>
					<gene>SYNE1</gene>
					<percent_reads>13.5%</percent_reads>
					<protein_effect>W1008S</protein_effect>
					<transcript>NM_182961</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.864del</cds_effect>
					<depth>1666</depth>
					<gene>TEK</gene>
					<percent_reads>28.0%</percent_reads>
					<protein_effect>C289fs</protein_effect>
					<transcript>NM_000459</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.5665C&gt;T</cds_effect>
					<depth>1424</depth>
					<gene>TET2</gene>
					<percent_reads>12.4%</percent_reads>
					<protein_effect>P1889S</protein_effect>
					<transcript>NM_001127208</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.622T&gt;C</cds_effect>
					<depth>410</depth>
					<gene>TPMT</gene>
					<percent_reads>59.0%</percent_reads>
					<protein_effect>F208L</protein_effect>
					<transcript>NM_000367</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1921C&gt;T</cds_effect>
					<depth>3865</depth>
					<gene>TSC1</gene>
					<percent_reads>74.4%</percent_reads>
					<protein_effect>P641S</protein_effect>
					<transcript>NM_000368</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.7068T&gt;G</cds_effect>
					<depth>2307</depth>
					<gene>USH2A</gene>
					<percent_reads>74.9%</percent_reads>
					<protein_effect>N2356K</protein_effect>
					<transcript>NM_206933</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.6832C&gt;A</cds_effect>
					<depth>2213</depth>
					<gene>USH2A</gene>
					<percent_reads>25.3%</percent_reads>
					<protein_effect>L2278I</protein_effect>
					<transcript>NM_206933</transcript>
				</short_variant>
			</short_variants>
			<copy_number_alterations>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>FLCN, TP53</gene>
					<position>Chr17</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>STK11</gene>
					<position>Chr19</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>FANCC</gene>
					<position>Chr9</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>8</copy_number>
					<gene>CCNE1</gene>
					<position>Chr19</position>
					<type>Amplification</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>13</copy_number>
					<gene>AKT2</gene>
					<position>Chr19</position>
					<type>Amplification</type>
				</copy_number_alteration>
			</copy_number_alterations>
			<rearrangements>
			</rearrangements>
			<biomarkers>
				<microsatellite_instability>
					<status>Microsatellite stable (MSS)</status>
				</microsatellite_instability>
				<tumor_mutation_burden>
					<score>13.1</score>
				</tumor_mutation_burden>
			</biomarkers>
		</variant-report>
	</rr:ResultsPayload>
</rr:ResultsReport>